Dividends Calendar Earnings Calendar
TLRY

TLRY | Tilray, Inc.

Healthcare sector
Tilray, Inc.
Category: Pharmaceutical company
  • Industry: Drug Manufacturers - Specialty & Generic

Quick infos

  • Headquarters:   Nanaimo, Canada

Trade prices

  • Volume: 80.2M
  • Market Cap: 1.41B
  • Prev closed:
  • Open: 5.82
  • High: 7.07
  • Low: 5.68
  • 52 week low: 4.78
  • 52 week high: 24.68
  • Dividends:No Dividends

Next ER: April 10, 2023  After Market Closes



Top Stories (TLRY)



    About the Company

    Tilray is a Canadian pharmaceutical and cannabis company, incorporated in the United States with primary operations headquartered in Nanaimo, British Columbia. Tilray also has operations in Australia & New Zealand, Germany, Portugal, and Latin America.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    July 6, 2023- / -0.05- / 159.1M
    April 10, 2023-1.9 / -0.05145.6M / 150.05M
    April 5, 2023-0.08 / -0.0545153.21M / 163.52M
    January 9, 2023-0.06 / -0.06144.1M / 156.85M
    October 7, 2022-0.13 / -0.0675153.21M / 155.87M
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Jun 15, 2023 1.61 1.65
    1.66
    1.6
    		 19.1M -1.83%
    Jun 14, 2023 1.64 1.72
    1.72
    1.6
    		 15.4M -4.09%
    Jun 13, 2023 1.71 1.7
    1.75
    1.67
    		 14.7M 2.40%
    Jun 12, 2023 1.67 1.6
    1.67
    1.56
    		 18.8M 5.03%
    Jun 9, 2023 1.59 1.68
    1.68
    1.58
    		 21.3M -4.79%
    Jun 8, 2023 1.67 1.73
    1.73
    1.65
    		 23.4M -3.47%
    Jun 7, 2023 1.73 1.79
    1.83
    1.7
    		 21.0M -2.26%
    Jun 6, 2023 1.77 1.69
    1.79
    1.66
    		 15.2M 4.73%
    Jun 5, 2023 1.69 1.75
    1.75
    1.64
    		 15.5M -1.74%
    Jun 2, 2023 1.72 1.75
    1.81
    1.71
    		 21.2M 1.18%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2013
    • Employees:750

    News

    News for (TLRY)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  Brendan Kennedy
    • CFO :  Mark Castaneda
    • General Counsel :  Dara Redler

    Talk about Tilray, Inc. below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Apr 10, 2023 (Same day)

    tlry nhwk 


    Jump to (Finance sites)

    Google   
             

    Research 


    Investor page

    ir.tilray.com

    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 27
    HOLD 64
    SELL 9

    Their Official Profiles 

    WikipediaTwitter

    Peers / Similar stocks 

    xlv 

    Other stocks 

    csco baba asna jpm sig cmc mtb chl etr afsi dxc docu 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Technical Analysis For Dummies
    Buy on Amazon

    Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.

    A simple, straightforward guide to the fundamentals of technical analysis